Investors
Investment opportunity
Seed Round 2026 · Pre-revenue · Five live products · Soft launch Dhaka. Building the care coordination layer for a US$19B+ Bangladesh health market.
Request materials · support@mukti.healthWhy now
US$19.4B
Health market TAM (context)
73%
Out-of-pocket spend — extreme friction
5
Connected products already live
64
District national roadmap
Seed Round 2026
Raising seed capital to deepen Dhaka density, complete verification operations, harden logistics SLAs, and prepare the next city wave. Cap table, use of funds, and data room available under NDA.
US$2.5M
Target raise
US$10.0M
Pre-money (illustrative)
US$12.5M
Post-money (illustrative)
20%
Equity offered (illustrative)
Figures from the Mukti Seed narrative are illustrative and negotiable. Final terms follow diligence.
Product
Reliability in ambulance, pharmacy quotes, Rx, and records
Network
Verified doctors, hospitals, pharmacies, riders in Dhaka
Ops
Admin Mission Control, settlements, support capacity
Valuation methodology
Mukti does not publish a single “formula price.” Seed valuation is framed as a negotiated range informed by stage, product reality, market context, and comparable digital health / multi-sided marketplace deals in South Asia and emerging markets. The methodology below is how we discuss value with partners under NDA.
1 · Market sizing
- TAM — Bangladesh health expenditure context (~US$19B scale) as the outer market Mukti coordinates into, not revenue we claim on day one.
- SAM — Digitally addressable outpatient, emergency logistics, and medicine fulfilment in launch metros (starting Dhaka).
- SOM — Share of completed, commissionable jobs (ambulance, pharmacy delivery, consults) we can realistically capture with verified supply.
2 · Stage & risk
- Pre-revenue seed — valuation weighted to team, product completeness, and go-to-market clarity rather than trailing revenue multiples.
- Execution risk — partner verification density, logistics SLAs, and regulatory/ops complexity in healthcare are priced into the range.
- De-risking already done — five live surfaces, shared identity graph, and soft-launch architecture reduce pure “idea-stage” discount.
3 · Comparable approach
- Reference bands from seed/Series A digital health, telemedicine, and on-demand logistics platforms in comparable markets (adjusted for Bangladesh GDP/capita, regulatory path, and capital market depth).
- Preference for platform / network comps over single-feature clinic apps, because Mukti’s thesis is multi-sided coordination.
- Public marketing pages stay qualitative; numeric comps and selected deal marks sit in the data room.
4 · Forward value drivers
- Unit economics — commission on completed jobs (ambulance, medicine, consults), not ad-driven vanity metrics.
- Network effects — more verified supply improves patient conversion; more demand improves partner ROI.
- Path to Series A — city density KPIs, retention, and contribution margin targets define the next valuation step-up narrative.
Illustrative seed frame
Working narrative for conversations: raise on the order of US$2.5M against an illustrative US$10M pre-money / US$12.5M post-money frame (~20% primary). This is a discussion anchor from the investor materials — not a binding offer. Instrument (priced equity, SAFE, or notes), option pool, and investor rights are finalized after diligence.
| Input | Illustrative | Role in method |
|---|---|---|
| Pre-money | US$10.0M | Stage + product + market context anchor |
| New capital | US$2.5M | Runway for Dhaka density & ops |
| Post-money | US$12.5M | Pre-money + primary capital |
| Primary ownership | ~20% | 2.5 / 12.5 — before pool fine-tuning |
What we do not use alone
Vanity downloads, unproven national TAM as revenue, or peer valuations without stage adjustment.
What moves the range up
Verified partner density, completed-job volume, contribution margin, multi-city readiness.
What moves the range down
Thin supply, weak SLAs, regulatory delays, or capital structure complexity.
5-year target (2026–2031)
Directional roadmap for partners and investors — not a guarantee of results. Execution depends on capital, regulation, and partner density.
| Horizon | Focus | Ambition |
|---|---|---|
| Year 1 | Dhaka soft launch | Reliable core loops · verified supply · invite growth |
| Year 2–3 | Multi-city expansion | Chittagong & selected metros · denser logistics |
| Year 4–5 | National coverage path | Broader district reach · deeper clinical integrations |
- • Default coordination layer for emergency, medicine delivery, and outpatient journeys in launch cities
- • Verified partner network measured by utilisation, not vanity installs
- • Sustainable unit economics: commissions on completed jobs, clear settlements
Process
Intro → NDA → data room (deck, model, legal basics) → partner call → term discussion. Valuation and instrument are finalized only after mutual diligence — public numbers remain illustrative.
Next step
Email support@mukti.health with a short background and investment focus. We respond with NDA and deck access for aligned partners.
Contact